Latest period
$86.7M
YoY change
-3.8%
5Y CAGR
+7.0%
Peak year (FY2021)
$352M
Latest annual
$288M
Operating Cash Flow history chart for Bio-Techne (TECH) from 2016 to 2025
Latest: $288M
Operating Cash Flow growth chart for Bio-Techne (TECH) from 2016 to 2025
Latest: -3.8%
Operating Cash Flow history table for Bio-Techne (TECH) from 1990 to 2025
| FY2025 | $288M | -3.8% | -$11.4M | ||
| FY2024 | $299M | +17.5% | +$44.6M | ||
| FY2023 | $254M | -21.8% | -$70.9M | ||
| FY2022 | $325M | -7.6% | -$26.9M | ||
| FY2021 | $352M | +71.6% | +$147M | ||
| FY2020 | $205M | +13.0% | +$23.6M | ||
| FY2019 | $182M | +6.6% | +$11.3M | ||
| FY2018 | $170M | +18.8% | +$26.9M | ||
| FY2017 | $143M | -0.3% | -$422K | ||
| FY2016 | $144M | +3.2% | +$4.51M | ||
| FY2015 | $139M | +1.9% | +$2.6M | ||
| FY2014 | $137M | +10.7% | +$13.2M | ||
| FY2013 | $124M | -2.5% | -$3.18M | ||
| FY2012 | $127M | -0.4% | -$448K | ||
| FY2011 | $127M | +14.3% | +$15.9M | ||
| FY2010 | $111M | -0.1% | -$61K | ||
| FY2009 | $111M | -3.5% | -$4M | ||
| FY2008 | $115M | +27.4% | +$24.8M | ||
| FY2007 | $90.5M | +5.7% | +$4.91M | ||
| FY2006 | $85.6M | +15.0% | +$11.2M | ||
| FY2005 | $74.4M | +13.5% | +$8.88M | ||
| FY2004 | $65.6M | +21.2% | +$11.5M | ||
| FY2003 | $54.1M | +95.5% | +$26.4M | ||
| FY2002 | $27.7M | -40.3% | -$18.7M | ||
| FY2001 | $46.4M | +19.7% | +$7.63M | ||
| FY2000 | $38.7M | +36.4% | +$10.3M | ||
| FY1999 | $28.4M | +39.9% | +$8.1M | ||
| FY1998 | $20.3M | +62.4% | +$7.8M | ||
| FY1997 | $12.5M | +27.6% | +$2.7M | ||
| FY1996 | $9.8M | +34.2% | +$2.5M | ||
| FY1995 | $7.3M | +15.9% | +$1M | ||
| FY1994 | $6.3M | +40.0% | +$1.8M | ||
| FY1993 | $4.5M | +15.4% | +$600K | ||
| FY1992 | $3.9M | +116.7% | +$2.1M | ||
| FY1991 | $1.8M | +63.6% | +$700K | ||
| FY1990 | $1.1M | — | — |
- FY2025$288M-3.8%
- FY2024$299M+17.5%
- FY2023$254M-21.8%
- FY2022$325M-7.6%
- FY2021$352M+71.6%
- FY2020$205M+13.0%
- FY2019$182M+6.6%
- FY2018$170M+18.8%
- FY2017$143M-0.3%
- FY2016$144M+3.2%
- FY2015$139M+1.9%
- FY2014$137M+10.7%
- FY2013$124M-2.5%
- FY2012$127M-0.4%
- FY2011$127M+14.3%
- FY2010$111M-0.1%
- FY2009$111M-3.5%
- FY2008$115M+27.4%
- FY2007$90.5M+5.7%
- FY2006$85.6M+15.0%
- FY2005$74.4M+13.5%
- FY2004$65.6M+21.2%
- FY2003$54.1M+95.5%
- FY2002$27.7M-40.3%
- FY2001$46.4M+19.7%
- FY2000$38.7M+36.4%
- FY1999$28.4M+39.9%
- FY1998$20.3M+62.4%
- FY1997$12.5M+27.6%
- FY1996$9.8M+34.2%
- FY1995$7.3M+15.9%
- FY1994$6.3M+40.0%
- FY1993$4.5M+15.4%
- FY1992$3.9M+116.7%
- FY1991$1.8M+63.6%
- FY1990$1.1M—
Operating Cash Flow values are taken from Bio-Techne's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Operating Cash Flow at Bio-Techne (TECH)
Operating Cash Flow for Bio-Techne (TECH): headline value $86.7M · YoY -3.8%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Bio-Techne (TECH) operating cash flow totalled $288M – edged down 3.8% year-over-year.
Over 2020–2025 (5 years), Bio-Techne operating cash flow expanded at a +7.0% compound annual rate, with mixed annual results across the window.
Bio-Techne operating cash flow peaked at $352M in 2021; the latest annual figure is $288M in 2025 (18.3% below peak).
The highest annual operating cash flow of $352M was reported in 2021. The lowest in the available history was $1.1M in 1990.
Bio-Techne Operating Cash Flow by Year
Bio-Techne Operating Cash Flow 2025: $288M
2025's operating cash flow for Bio-Techne came in at $288M, edged down 3.8% below 2024.
Bio-Techne Operating Cash Flow 2024: $299M
Bio-Techne posted operating cash flow of $299M in 2024, grew 17.5% from 2023.
Bio-Techne Operating Cash Flow 2023: $254M
In 2023, Bio-Techne reported operating cash flow of $254M, declined 21.8% below 2022.
Bio-Techne Operating Cash Flow 2022: $325M
Bio-Techne operating cash flow in 2022 was $325M, declined 7.6% below 2021.
Bio-Techne Operating Cash Flow 2021: $352M
Bio-Techne operating cash flow in 2021 was $352M.
See more financial history for Bio-Techne (TECH).
Sector peers by Operating Cash Flow
Healthcare peers of Bio-Techne (TECH), ranked by their latest operating cash flow
| $24.5B | |
| $19.7B | |
| $19B | |
| $18.6B | |
| $16.8B | |
| $16.5B | |
| $9.96B | |
| $7.82B |
- $24.5B
- $19.7B
- $19B
- $18.6B
- $16.8B
- $16.5B
- $9.96B
Frequently asked questions
Bio-Techne (TECH) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks1.23% TTM
- Dividend Profile0.45% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History3 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.